The trading price of Mainz Biomed N.V. (NASDAQ:MYNZ) closed higher on Tuesday, October 29, and closing at $0.27, 5.47% higher than its previous close.
Traders who pay close attention to intraday price movement should know that it fluctuated between $0.235 and $0.2869. In examining the 52-week price action we see that the stock hit a 52-week high of $3.39 and a 52-week low of $0.19. Over the past month, the stock has gained 8.43% in value.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Mainz Biomed N.V., whose market valuation is $5.91 million at the time of this writing, is expected to release its quarterly earnings report in November. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by -0.25 per share this quarter, however they have predicted annual earnings per share of -0.87 for current year and -0.74 for next year.
Analysts have forecast the company to bring in revenue of 220k for the current quarter, with the likely lows of 200k and highs of 250k. From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue is 1.2M.
On the technical side, indicators suggest MYNZ has a 100% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.
A quick review shows that MYNZ’s price is currently -7.10% off the SMA20 and -10.46% off the SMA50. The RSI metric on the 14-day chart is currently showing 46.32, and weekly volatility stands at 16.33%. When measured over the past 30 days, the indicator reaches 17.05%. Mainz Biomed N.V. (NASDAQ:MYNZ)’s beta value is currently sitting at 0.09, while the Average True Range indicator is currently displaying 0.04.
To see how Mainz Biomed N.V. stock has been performing in comparison to its peers in the industry, here are the numbers: MYNZ stock’s performance was 5.47% in the latest trading, and -86.43% in the past year.
An evaluation of the daily trading volume of Mainz Biomed N.V. (NASDAQ:MYNZ) indicates that the 3-month average is 2.06 million. However, this figure has increased over the past 10 days to an average of 2.25.
Currently, records show that 21.17 million of the company’s shares remain outstanding. The insiders hold 20.22% of outstanding shares, whereas institutions hold 0.56%. The stats also highlight that short interest as of 2024-10-15, stood at 1.7 million shares, resulting in a short ratio of 0.66 at that time. From this, we can conclude that short interest is 772.00 of the company’s total outstanding shares. It is noteworthy that short shares in October were up slightly from the previous month’s figure, which was 0.72 million. However, since the stock’s price has seen -76.72% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
